IL-6 Genomic Variants and Risk of Prostate Cancer.

CONCLUSION: Consequently, the results of the current study provide further evidence for contribution of IL-6 in prostate cancer. PMID: 30345492 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30345492?dopt=Abstract

Source: Urology Journal - October 21, 2018 Category: Urology & Nephrology Authors: Taheri M, Noroozi R, Rakhshan A, Ghanbari M, Omrani MD, Ghafouri-Fard S Tags: Urol J Source Type: research